Film coated tablet / Syrup

COMPOSITION:

Each film coated tablet contains 10 mg Cetirizine Dihydrochloride.

Each chewable tablet contains 10 mg Cetirizine Dihydrochloride.

Each chewable tablet contains 5 mg Cetirizine Dihydrochloride.

Each 5 ml of syrup contains 5 mg Cetirizine Dihydrochloride.

Pharmacotherapeutic group: Piperazine derivatives. Cetirizine, a human metabolite of hydroxyzine, is a potent and selective antagonist of peripheral H1-receptors.

INDICATIONS:

For the treatment of perennial rhinitis, seasonal allergic rhinitis (hay fever) and chronic idiopathic urticaria in adults and children aged 6 years and over, and for seasonal rhinitis (hay fever) in children aged between 6  months to 5 years.

POSOLOGY AND METHOD OF ADMINISTRATION:

• Adults and children 6 years and above: 10 mg daily.
• Adults and children aged 12 years and above: 10 ml once daily.
• Children aged between 6 to 11 years: Either 5 ml twice daily or 10 ml once daily.
• Children aged between 6 months – 5 years: 5 mg daily. Either 5 ml once daily or 2.5 ml twice daily.
• Elderly: data do not suggest that the dose needs to be reduced in elderly subjects provided that the renal function is normal.
• Patients with moderate to severe renal impairment: there are no data to document the efficacy/safety ratio patients with renal impairment. Since cetirizine is mainly excreted via renal route in cases where no alternative treatment can be used, the dosing intervals must be individualized according to renal function.
• Patients with hepatic impairment: no dose adjustment is needed in patients with solely hepatic impairment.

PACKAGING:

Pack of  30 Film Coated Tablets.

Pack of  30 chewable  Tablets.

Zetrizin Syrup: a glass brown container, contains 100ml syrup in carton box